Patterns of comorbidities differentially affect long-term functional evolution and disease activity in patients with ‘difficult to treat’ rheumatoid arthritis
Background Characterisation of the long-term outcome of patients with ‘difficult to treat’ (D2T) rheumatoid arthritis and factors contributing to its evolution are unknown. Herein, we explored the heterogeneity and contributing factors of D2T long-term outcome.Methods Patients included from a prospe...
Main Authors: | Prodromos Sidiropoulos, George Bertsias, Argyro Repa, Eleni Kalogiannaki, Antonios Bertsias, Nestor Avgoustidis, Sofia Pitsigavdaki, Irini D Flouri |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2024-02-01
|
Series: | RMD Open |
Online Access: | https://rmdopen.bmj.com/content/10/1/e003808.full |
Similar Items
-
Rheumatoid arthritis patients initiating rituximab with low number of previous bDMARDs failures may effectively reduce rituximab dose and experience fewer serious adverse events than patients on full dose: a 5-year cohort study
by: Antonios Bertsias, et al.
Published: (2022-06-01) -
A Peripheral Blood Signature of Increased Th1 and Myeloid Cells Combined with Serum Inflammatory Mediators Is Associated with Response to Abatacept in Rheumatoid Arthritis Patients
by: Panagiota Goutakoli, et al.
Published: (2023-12-01) -
Clinical response trajectories and drug persistence in systemic lupus erythematosus patients on belimumab treatment: A real-life, multicentre observational study
by: Myrto Nikoloudaki, et al.
Published: (2023-01-01) -
P70 Exposure to DORIS ≥50% of time and to LLDAS ≥60% of observation time exhibit the best combination of feasibility and protection against adverse outcomes in moderate-to-severe SLE
by: Alessandra Bortoluzzi, et al.
Published: (2024-03-01) -
Combination of clinical factors predicts successful glucocorticoid withdrawal in systemic lupus erythematosus (SLE): results from a multicentre, retrospective cohort study
by: Alessandra Bortoluzzi, et al.
Published: (2025-01-01)